Goldman Sachs’s Pulmatrix PULM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-2,904
Closed -$60K 6456
2021
Q2
$60K Sell
2,904
-4,109
-59% -$83.2K ﹤0.01% 6043
2021
Q1
$187K Buy
7,013
+5,302
+310% +$162K ﹤0.01% 5673
2020
Q4
$41K Buy
+1,711
New +$40.8K ﹤0.01% 5397
2020
Q3
Sell
-1,528
Closed -$53K 5505
2020
Q2
$53K Buy
+1,528
New +$48.4K ﹤0.01% 5061
2015
Q4
Sell
-94
Closed -$92K 7304
2015
Q3
$92K Buy
+94
New +$118K ﹤0.01% 6537

Other funds holding PULM

Goldman Sachs's PULM Position: Q3 2021 in Review

Goldman Sachs sold out of Pulmatrix (PULM) in Q3 2021, closing a stake of 2,904 shares — an estimated $60K sold.

Goldman Sachs first reported a position in PULM in Q3 2015 and held it in 5 quarters. The position peaked at $187K in Q1 2021. 20 funds tracked by Wall St. Rank hold PULM as of Q3 2021.

  • Goldman Sachs reported no remaining Pulmatrix position as of Q3 2021 after selling out during the quarter.
  • Goldman Sachs sold 2,904 Pulmatrix shares in Q3 2021, an estimated $60K.
  • Goldman Sachs first reported a position in Pulmatrix in Q3 2015 and held it in 5 quarters.
  • Goldman Sachs's Pulmatrix position peaked at $187K in Q1 2021.
  • 20 funds tracked by Wall St. Rank held Pulmatrix as of Q3 2021.

Based on Goldman Sachs's 13F filing for Q3 2021, filed 10 Nov 2021.